PATENT CLAIM ANALYSIS

Application Number: 15865214
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "186100"]

Abstract:
The present specification discloses recombinant nucleic acid constructs encoding an immunogenic multiepitope polypeptide comprising two or more polypeptides, recombinant nucleic acid constructs encoding at least two epitopes from two or more internal proteins of influenza virus, compositions comprising such recombinant nucleic acid constructs and methods of eliciting a T cell immune response against an influenza virus in a vertebrate using such recombinant nucleic acid constructs and compositions.

Claim (Index 14):
The composition according to  claim 8  further comprising an adjuvant.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 86.0
- Lexical Diversity: 1.62791
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13906232', '15231347', '12278728', '13465940', '14656690']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8185814235813498
- 35 USC 102 Novelty (BERT): 0.6203259311592703
- Combined Prediction Score: 0.7987558743391419
- Mean Citation Score: 645.4664999999999
- Max Citation Score: 666.0691
- Similarity Product: 504.74159455951457

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test